Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27110,125,1.10 [0.66-1.82],0.71115143296637
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27872,209,1.15 [0.78-1.71],0.4735701723557709
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27588,1367,1.01 [0.87-1.18],0.8722097672817237
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Candidiasis,27900,481,0.90 [0.69-1.16],0.4143811403642108
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27033,3577,1.01 [0.92-1.11],0.8020486102474286
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27266,2934,1.14 [1.02-1.27],0.0156612330412158
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27603,1395,1.14 [0.98-1.33],0.0958253197673879
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27789,92,1.50 [0.83-2.69],0.1787216506022703
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26005,835,1.10 [0.91-1.35],0.3239187853516042
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25145,979,1.22 [1.02-1.47],0.028850159012538
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25173,265,1.07 [0.75-1.51],0.7142743662976572
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19568,1710,1.07 [0.94-1.23],0.31220064583031
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24934,383,1.48 [1.11-1.97],0.0081847099552824
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27838,1630,1.13 [0.98-1.30],0.0854254827924176
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,27967,548,0.89 [0.70-1.13],0.3404027908940865
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27192,971,1.01 [0.84-1.21],0.9165750194056532
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27909,924,1.09 [0.91-1.32],0.3542165018589159
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26417,209,1.16 [0.79-1.72],0.4471669062868846
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28029,46,1.73 [0.76-3.96],0.1943133690816676
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27792,807,1.12 [0.92-1.36],0.2758901214031412
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27782,85,1.00 [0.54-1.85],0.9981504611769432
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27929,197,1.42 [0.95-2.12],0.0906748997597883
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27911,179,1.38 [0.90-2.11],0.1353477925924389
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26573,352,0.96 [0.71-1.30],0.7815175250845091
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26492,271,1.07 [0.76-1.51],0.6892309020169374
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26342,134,1.42 [0.87-2.30],0.1590457214321759
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28005,37,1.42 [0.57-3.56],0.4520661179478897
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27951,163,0.86 [0.55-1.35],0.5123308352547843
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral warts,27836,48,1.47 [0.65-3.32],0.3584739512673671
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27868,80,0.38 [0.20-0.71],0.0026085039299467
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,27752,246,0.74 [0.51-1.06],0.0997720005598214
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27923,72,0.71 [0.36-1.39],0.3168816494126856
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27919,71,1.06 [0.54-2.07],0.8690738716993944
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27734,1252,0.80 [0.68-0.94],0.0078652594751102
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of meninges,28001,81,1.27 [0.67-2.39],0.4641086093976515
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27960,66,0.50 [0.25-1.02],0.0566822926313593
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27994,136,1.06 [0.66-1.72],0.8076577174766353
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of ovary,27943,181,0.89 [0.58-1.36],0.5956975240477589
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28007,287,1.00 [0.71-1.40],0.9920461324093972
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Caecum,28013,258,0.96 [0.67-1.37],0.8303177010210139
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27939,67,1.27 [0.64-2.52],0.5029290496003037
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Descending colon,28010,157,0.55 [0.35-0.87],0.0101854463871441
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,27971,285,0.84 [0.60-1.17],0.3031289838188864
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27920,510,0.82 [0.64-1.06],0.1261727592675274
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28008,306,0.68 [0.49-0.94],0.0182233668312792
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Carcinoma in situ of breast,22715,138,0.73 [0.45-1.19],0.2071811736842745
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22808,168,0.60 [0.39-0.94],0.025051021961374
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22785,32,0.95 [0.34-2.63],0.9181653473740252
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22821,68,1.01 [0.50-2.02],0.9856618725652336
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27961,138,0.85 [0.52-1.38],0.5027939189534165
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",27962,136,0.86 [0.53-1.41],0.5478981543583938
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,27016,598,0.85 [0.68-1.08],0.1862310100572723
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lung cancer and mesothelioma,20099,320,0.54 [0.40-0.74],0.0001246315869895
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lymphoid leukaemia,22791,38,0.78 [0.30-1.99],0.599455544232053
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22932,179,1.32 [0.86-2.04],0.2080595687438372
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22868,115,0.93 [0.54-1.58],0.7761093845966849
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22944,191,1.28 [0.85-1.94],0.2364150485149389
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22821,68,0.78 [0.39-1.57],0.4919679527477554
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22825,72,0.81 [0.41-1.58],0.530615231565694
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22811,58,0.57 [0.27-1.20],0.1381674408503287
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22898,145,1.69 [1.05-2.71],0.0312743653456445
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22856,103,1.66 [0.95-2.90],0.074812503069867
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22839,86,1.97 [1.07-3.64],0.0303482540850225
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22796,43,1.07 [0.44-2.56],0.8875307610846832
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22833,80,0.54 [0.28-1.03],0.062429481534452
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,27763,237,0.76 [0.52-1.10],0.140302645658329
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of trunk,27981,82,0.41 [0.22-0.77],0.0054348265406729
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanoma in situ,22788,90,0.94 [0.51-1.74],0.8490342207010173
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22835,82,0.92 [0.49-1.73],0.7851594242673403
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22906,153,0.91 [0.57-1.46],0.7074135412858888
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22984,231,0.56 [0.39-0.81],0.0021705844352189
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22846,93,0.83 [0.46-1.51],0.5502830894469277
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,27802,172,0.96 [0.62-1.48],0.8387263186356402
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23714,961,1.20 [1.00-1.45],0.0540392136614601
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23754,1001,1.19 [0.99-1.43],0.0595907831959216
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27714,380,1.12 [0.84-1.50],0.447256538760833
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25967,105,4.90 [2.84-8.44],1.0136997186666844e-08
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27406,72,1.07 [0.55-2.08],0.8465756321972745
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26995,3046,1.15 [1.03-1.27],0.0092765676226862
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26346,37,2.56 [1.05-6.26],0.0389558411990981
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27615,49,1.03 [0.46-2.32],0.9403979452143012
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27435,1573,1.20 [1.04-1.38],0.0143146873911233
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27435,1573,1.20 [1.04-1.38],0.0143146873911233
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25933,71,1.87 [0.95-3.67],0.0694073914556735
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27610,1301,1.20 [1.02-1.40],0.0260670790840312
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27690,124,1.45 [0.87-2.42],0.1497763815836514
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27388,54,0.40 [0.19-0.85],0.0177863064538177
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27393,59,1.21 [0.58-2.52],0.6169698760042693
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27810,244,1.61 [1.12-2.32],0.0099469060432989
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27914,63,1.06 [0.52-2.15],0.8800903196033768
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27772,206,1.50 [1.01-2.23],0.044465916849463
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26445,136,0.78 [0.48-1.27],0.3189445973870344
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22554,260,0.97 [0.68-1.38],0.864179057153556
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26576,68,0.48 [0.24-0.94],0.032713871572162
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26574,66,0.56 [0.38-0.84],0.0047968093593392
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22348,54,0.43 [0.20-0.95],0.0355365400090605
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25712,72,1.29 [0.66-2.49],0.4566444157327332
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25331,249,0.97 [0.68-1.39],0.8779150244204643
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27581,518,0.98 [0.76-1.26],0.8604435815238882
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27356,293,1.30 [0.93-1.82],0.1211638036999816
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27151,88,1.13 [0.62-2.07],0.6941324115447667
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27624,1984,0.85 [0.75-0.96],0.0113622967570806
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24803,1932,0.82 [0.72-0.94],0.003359902714076
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22354,60,0.64 [0.31-1.35],0.2404581596277848
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24851,120,1.17 [0.69-1.97],0.5582928503199651
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22580,286,1.21 [0.87-1.70],0.2612399991447405
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22342,48,0.65 [0.28-1.50],0.3157035299450882
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25515,3221,0.77 [0.70-0.85],3.2512118268941e-07
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22497,203,0.94 [0.63-1.41],0.7589794032953529
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22837,543,1.02 [0.80-1.31],0.8517376525452692
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27922,375,1.35 [1.00-1.80],0.0468226905294755
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27731,184,2.45 [1.63-3.69],1.666347817723129e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22394,100,1.04 [0.58-1.84],0.904462142989752
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22351,57,1.83 [0.86-3.89],0.1182528009735167
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27115,2384,1.13 [1.00-1.27],0.0457797218809234
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22509,215,1.75 [1.19-2.57],0.00416098887777
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22511,217,2.19 [1.50-3.20],4.469531894903671e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22835,541,0.98 [0.76-1.25],0.842422512888307
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22391,97,0.78 [0.44-1.40],0.405590819565503
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27721,174,2.53 [1.67-3.85],1.3704745430054884e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22935,641,0.91 [0.73-1.15],0.4389178033060682
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22867,573,0.78 [0.61-0.99],0.0395950154934454
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25153,71,1.95 [1.00-3.79],0.0492202628051309
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27103,4809,0.86 [0.79-0.94],0.000386711770881
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24810,79,1.08 [0.57-2.05],0.8077187874994016
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24820,89,0.60 [0.32-1.10],0.0956045343780944
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27825,2132,0.85 [0.76-0.96],0.0100400242968564
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27830,2131,0.85 [0.76-0.96],0.0097769542290776
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24813,82,1.11 [0.59-2.09],0.7397916103977141
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27611,1621,0.80 [0.70-0.92],0.002176933086105
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23851,1557,1.00 [0.86-1.15],0.9667281567978196
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28014,187,1.73 [1.15-2.59],0.0080319731953541
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27122,59,1.14 [0.54-2.39],0.7272972475713291
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26126,136,1.02 [0.62-1.65],0.9493097693530076
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26194,204,0.72 [0.48-1.07],0.1020373875600871
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22565,271,1.12 [0.79-1.59],0.5185900488088975
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26153,143,2.53 [1.59-4.04],9.975877587443614e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1748,49,1.58 [0.74-3.37],0.2384222620257255
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1863,188,1.56 [1.07-2.29],0.0222416327543762
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26036,26,3.03 [1.03-8.94],0.0444807568743654
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1729,31,6.68 [2.68-16.65],4.535199183396116e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27532,1522,0.95 [0.82-1.09],0.4461915459616222
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27409,346,0.97 [0.71-1.32],0.8450939538908606
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25572,490,0.98 [0.76-1.27],0.8849810345978886
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23037,743,1.32 [1.07-1.63],0.0100322400036087
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27927,234,1.79 [1.24-2.59],0.0018276922700412
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26997,52,1.52 [0.70-3.29],0.2940207414610249
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,26461,898,0.81 [0.67-0.98],0.0273692354083945
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27039,94,1.18 [0.66-2.12],0.5728390577132747
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26981,36,0.92 [0.36-2.36],0.8619102462799366
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27096,151,0.99 [0.62-1.56],0.9519818905157902
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18235,1514,0.79 [0.68-0.92],0.0025347540246456
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,AV-block,24529,243,0.74 [0.51-1.07],0.1121031675160523
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27985,310,1.08 [0.79-1.49],0.6256948375625451
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiac arrest,16852,131,1.04 [0.62-1.74],0.8751016781487323
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24422,136,0.71 [0.43-1.16],0.1681828526164601
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24364,78,0.87 [0.45-1.66],0.6699170872808893
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28025,33,0.66 [0.25-1.77],0.4106480053611193
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,25029,743,0.84 [0.68-1.04],0.1172098214914942
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27090,1539,0.89 [0.77-1.02],0.0993070862593224
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25187,7404,0.85 [0.79-0.90],1.012960118921923e-06
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26479,249,1.72 [1.20-2.46],0.0028735534865992
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Endocarditis,24349,63,1.42 [0.69-2.92],0.3370327114171103
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27927,880,0.84 [0.70-1.02],0.0800405117819045
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,25828,6262,0.82 [0.76-0.88],4.085118725168456e-08
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25841,6275,0.82 [0.76-0.88],1.364275820943138e-07
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27913,45,1.31 [0.57-3.04],0.5218719317986881
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19734,168,1.16 [0.74-1.81],0.5267980939630289
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19669,103,11.73 [6.78-20.29],1.22807772625195e-18
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,27885,1126,1.22 [1.03-1.44],0.0227434063615642
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27256,98,0.75 [0.42-1.33],0.3257170935283285
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27290,1727,0.84 [0.74-0.97],0.014490544186674
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27708,467,0.84 [0.65-1.09],0.1948557828462178
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24593,307,0.77 [0.55-1.07],0.1188147877818583
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27797,620,1.12 [0.89-1.40],0.3463457960113373
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26061,498,1.18 [0.91-1.52],0.2120727436943572
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28002,89,0.59 [0.32-1.07],0.0838134335191526
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28021,246,1.41 [0.98-2.02],0.0618956087199266
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Oesophageal varices,26269,39,1.44 [0.58-3.55],0.4304390270454861
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other aneurysm,27004,59,0.68 [0.32-1.43],0.3116926458845672
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,24653,367,0.94 [0.69-1.26],0.6688897958724442
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27013,68,1.01 [0.51-2.00],0.9777069950900192
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27144,199,1.20 [0.80-1.80],0.3686053428985214
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24447,161,0.75 [0.48-1.18],0.208797562925068
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other disorders of veins,26328,98,0.72 [0.41-1.27],0.2590285203198437
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26275,45,1.21 [0.52-2.82],0.652706553744673
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26752,40,0.74 [0.30-1.83],0.5171918145569929
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26399,169,0.79 [0.51-1.23],0.2976876868204544
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25112,826,0.93 [0.76-1.14],0.4949178262617423
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26803,44,1.38 [0.59-3.23],0.4631670137717955
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27460,515,0.92 [0.72-1.19],0.5361976998955017
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27440,328,0.93 [0.68-1.27],0.6337301739474457
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27267,555,0.87 [0.68-1.11],0.2636818659616196
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,17017,296,0.74 [0.53-1.04],0.0864783538623227
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27210,279,0.89 [0.64-1.25],0.5036934563750933
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26561,331,1.63 [1.19-2.22],0.0021247950634063
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27565,453,1.30 [1.00-1.70],0.0513982017783922
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27948,602,0.99 [0.78-1.24],0.9027055387174714
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24513,227,0.77 [0.52-1.13],0.1748438855929243
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27431,319,0.92 [0.67-1.26],0.6126129729605431
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26876,164,0.88 [0.57-1.38],0.5855233365398009
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27701,543,0.82 [0.64-1.04],0.1060374689262915
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27676,591,0.95 [0.75-1.19],0.6376753187464277
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27222,72,2.25 [1.17-4.33],0.0153488994234089
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26991,46,0.66 [0.29-1.54],0.3405966772455052
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27462,221,0.85 [0.58-1.24],0.394198818306857
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27382,205,0.94 [0.64-1.39],0.760156766304523
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,26696,466,1.24 [0.95-1.61],0.1103835093497679
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26954,96,0.82 [0.46-1.46],0.4946759585902744
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27811,716,1.45 [1.18-1.80],0.0005048834172666
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27983,221,0.42 [0.29-0.62],8.078294543829827e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24895,1890,0.80 [0.70-0.91],0.0009268515407956
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,27405,4400,0.84 [0.77-0.92],7.514717035714467e-05
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27951,262,0.42 [0.30-0.60],1.1264628290635322e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25011,2006,0.83 [0.73-0.95],0.0046815898570506
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23102,97,0.74 [0.42-1.31],0.3039151329288042
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,27605,1217,0.74 [0.63-0.87],0.0002626047645915
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24408,1403,0.72 [0.62-0.84],2.0364473046402875e-05
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Vascular dementia,27512,102,1.15 [0.65-2.02],0.63149836728012
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Alzheimer disease,28029,366,1.24 [0.92-1.67],0.159810626271286
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",19141,60,2.73 [1.36-5.49],0.0047510705053327
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Bell's palsy,25828,84,0.75 [0.41-1.40],0.3734198870425894
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26391,647,1.11 [0.89-1.38],0.3728547404109469
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral cysts,27612,224,1.05 [0.72-1.53],0.8126030788635592
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27954,284,0.65 [0.46-0.91],0.0117784616870455
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27533,41,1.25 [0.51-3.05],0.6198720383912617
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28014,47,1.03 [0.45-2.35],0.9481160457960056
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27443,55,1.53 [0.71-3.32],0.2760799478123219
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,26507,288,1.16 [0.83-1.62],0.3984122363430651
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27602,1383,0.95 [0.81-1.10],0.4703189569312691
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27980,524,0.98 [0.77-1.26],0.8821995031617254
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27377,2963,1.00 [0.90-1.12],0.9286969382897756
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Generalized epilepsy,27650,48,1.37 [0.61-3.11],0.4467123205201037
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,27896,226,0.71 [0.49-1.04],0.0798652254589055
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hydrocephalus,27456,68,1.23 [0.62-2.45],0.5565990907758148
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28008,79,1.01 [0.53-1.91],0.986555259323829
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25873,129,1.13 [0.68-1.87],0.6443540125170675
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25812,68,0.38 [0.19-0.75],0.0053978908606469
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Memory loss,27384,98,0.76 [0.43-1.35],0.3517717589993083
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,26743,524,0.92 [0.72-1.19],0.5282182345231838
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27911,472,0.90 [0.69-1.17],0.4133033484339051
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Motor neuron disease,19232,124,0.81 [0.48-1.37],0.4288848875050944
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27803,145,0.71 [0.44-1.15],0.1671155872861457
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27163,1419,0.98 [0.84-1.14],0.7669695084172159
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,26379,3885,0.95 [0.87-1.05],0.3243904763872167
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27653,161,1.08 [0.69-1.69],0.7385713118507601
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26174,430,1.02 [0.77-1.34],0.8869461906462853
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27969,240,2.12 [1.48-3.04],4.692852196116208e-05
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22578,678,1.08 [0.86-1.35],0.4996292636592448
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27456,68,0.73 [0.37-1.45],0.3660184418594501
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27515,127,1.36 [0.82-2.23],0.2324678428909725
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27644,188,1.14 [0.75-1.72],0.5431875127015382
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25839,95,0.81 [0.45-1.46],0.4868145105529217
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other headache syndromes,26296,77,0.89 [0.47-1.70],0.7282779940956247
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,27904,516,0.98 [0.76-1.25],0.84424026315118
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,26635,416,0.90 [0.68-1.18],0.4362736624114099
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Parkinson's disease,28004,317,0.96 [0.70-1.33],0.8270281064672959
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27472,84,0.78 [0.42-1.46],0.4421886307662915
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Restless leg syndrome,28027,105,1.45 [0.84-2.52],0.1850267584033548
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,27845,329,0.74 [0.54-1.01],0.0545394018144083
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27770,41,1.13 [0.46-2.76],0.7891154491389852
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28018,153,0.78 [0.49-1.24],0.3016647560028605
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25813,69,0.57 [0.29-1.12],0.1030982149076337
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28029,370,1.24 [0.92-1.66],0.1587238146799605
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27468,99,1.18 [0.67-2.10],0.562683011717638
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27434,112,0.89 [0.52-1.52],0.6681355826515489
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27551,497,0.97 [0.75-1.26],0.8354124586396579
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27878,175,1.56 [1.03-2.37],0.0361324021200015
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26891,63,0.63 [0.31-1.30],0.2135458770192195
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26882,54,0.99 [0.45-2.18],0.989503217539662
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27903,60,0.69 [0.33-1.43],0.3206794914310276
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27735,171,1.19 [0.77-1.83],0.4376939604137785
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1736,37,5.88 [2.56-13.50],2.9748449694200328e-05
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2088,72,2.59 [1.43-4.71],0.0017368212469679
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27415,93,1.25 [0.70-2.26],0.45088324091539
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27842,1080,1.14 [0.96-1.36],0.131385045431459
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27598,770,0.89 [0.72-1.09],0.2514476554604629
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27131,303,0.96 [0.69-1.34],0.8131409426415921
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27933,879,0.96 [0.80-1.17],0.7152807895603563
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28012,72,1.46 [0.75-2.85],0.2642703743829537
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27853,799,0.98 [0.80-1.20],0.8657067556770546
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27979,415,1.04 [0.79-1.38],0.758735694632431
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27929,210,1.12 [0.76-1.65],0.5800331753693394
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26868,40,0.38 [0.15-0.93],0.0333788832277818
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26877,49,0.62 [0.27-1.39],0.2446306989165828
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26896,68,0.74 [0.37-1.47],0.3853199410268952
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27934,732,0.92 [0.75-1.14],0.4652262433340977
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27388,186,1.22 [0.80-1.84],0.3579681965032537
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27121,67,0.78 [0.39-1.56],0.4776630773943578
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27666,102,0.83 [0.47-1.45],0.5044794134556276
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27886,322,1.09 [0.80-1.50],0.5755253030005256
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27272,218,1.05 [0.71-1.54],0.8195984379538456
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27856,137,1.22 [0.75-1.99],0.4149887267909717
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27685,483,0.98 [0.75-1.27],0.8563490763324414
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27473,151,0.84 [0.53-1.34],0.4708735937041447
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26189,2573,0.95 [0.84-1.06],0.3296697406003845
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27844,280,1.13 [0.80-1.59],0.4816306655865624
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28002,158,1.30 [0.83-2.05],0.2527716784692562
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27229,401,0.93 [0.70-1.24],0.6239466192542504
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27626,62,0.76 [0.37-1.57],0.4634704417231836
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27997,57,1.54 [0.73-3.27],0.2582073710034291
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26921,93,1.10 [0.61-1.99],0.746326010059928
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26984,156,1.05 [0.66-1.66],0.8430389663634593
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26871,109,1.09 [0.63-1.88],0.7656881083819511
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27126,72,0.82 [0.42-1.61],0.5687206836676653
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26824,62,0.60 [0.29-1.24],0.1664463758040738
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27324,122,0.77 [0.46-1.28],0.3123585322280168
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27384,182,1.11 [0.73-1.70],0.6251849309150092
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26965,137,0.96 [0.59-1.57],0.8773758575985284
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26861,99,0.97 [0.54-1.74],0.9311529529273694
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26838,76,1.01 [0.53-1.95],0.9692996663159794
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25763,2147,0.95 [0.84-1.08],0.4216727785696815
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26915,87,0.98 [0.53-1.81],0.9504828948897396
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27756,434,0.90 [0.69-1.18],0.45312851649144
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27371,49,0.62 [0.28-1.38],0.2395241675604733
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27496,174,1.04 [0.68-1.61],0.8481569191253251
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27779,119,1.00 [0.59-1.69],0.995608362020696
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27980,118,1.37 [0.81-2.31],0.236525581857688
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27898,149,0.92 [0.58-1.47],0.7395480545940217
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27730,70,0.89 [0.45-1.76],0.742624168774191
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,27732,72,1.26 [0.64-2.48],0.4996999763339003
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27927,832,1.02 [0.84-1.25],0.8219630483740257
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27664,569,1.04 [0.82-1.33],0.7182999906013641
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27220,125,1.04 [0.63-1.73],0.8825323309736257
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27182,87,0.69 [0.38-1.27],0.2371966026555962
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute pharyngitis,27751,87,0.70 [0.38-1.29],0.2513618069274244
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27901,237,1.00 [0.69-1.44],0.992356667153257
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27730,66,1.28 [0.64-2.58],0.4824785290777194
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza,26258,131,2.22 [1.35-3.63],0.0015442447027832
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26256,129,2.20 [1.34-3.61],0.0019045945993241
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19907,128,0.59 [0.35-0.98],0.0432412173489967
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic rhinitis,27870,293,0.73 [0.52-1.02],0.0643690851498367
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21696,2111,0.86 [0.76-0.97],0.0178623898824089
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21864,2085,0.85 [0.75-0.97],0.0148175612665297
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27595,129,1.74 [1.06-2.86],0.0278366373439312
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26196,69,1.50 [0.76-2.97],0.2444991410350314
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bronchiectasis,24239,420,0.59 [0.45-0.78],0.0002070481983961
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23892,73,0.73 [0.37-1.42],0.3565438608494788
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26845,3026,0.82 [0.74-0.92],0.0002745624669232
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26720,61,0.93 [0.45-1.94],0.8476758773787538
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,26806,147,0.62 [0.38-0.99],0.0432148532428548
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27849,1081,0.77 [0.65-0.91],0.0029106127475645
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,26732,73,0.73 [0.37-1.42],0.3528200953159166
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25892,5273,0.89 [0.82-0.96],0.0029195738192919
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26994,335,0.75 [0.55-1.02],0.0644030113490497
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,27090,322,0.83 [0.61-1.14],0.2560511428353318
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Emphysema,24097,278,0.79 [0.56-1.11],0.179942589132673
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26357,234,1.02 [0.70-1.48],0.9154612409988456
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27827,1700,0.95 [0.83-1.09],0.4685780365111172
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,26398,275,1.00 [0.71-1.41],0.9922693293895284
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Later onset COPD,27092,759,0.72 [0.59-0.89],0.0020453962390521
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28020,231,0.69 [0.47-1.00],0.0488991986292995
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,26729,70,0.69 [0.35-1.38],0.2960421573655249
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27798,945,1.12 [0.93-1.35],0.2334537319674815
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,27835,1792,0.94 [0.82-1.08],0.3779865460253772
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27458,799,0.76 [0.62-0.93],0.0085890980049497
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other pleural conditions,26080,37,1.68 [0.65-4.30],0.2824164873237234
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27945,352,1.24 [0.92-1.68],0.1544162182350059
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27937,1207,0.89 [0.76-1.05],0.1795400928904883
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,26914,871,1.03 [0.85-1.25],0.7895342911727011
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural plaque,26089,46,1.88 [0.82-4.31],0.1379187859652955
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27586,1459,0.93 [0.80-1.08],0.3659085766302907
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27991,202,0.66 [0.44-0.98],0.0413456500802204
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumothorax,26135,92,0.63 [0.34-1.14],0.124369772901929
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pollen allergy,27995,245,0.71 [0.49-1.02],0.0610852954341473
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pulmonary oedema,27657,64,2.11 [1.06-4.23],0.034500025995093
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19832,53,0.31 [0.14-0.67],0.0027666234726687
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27772,919,1.14 [0.94-1.37],0.1805318056035367
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26952,293,0.73 [0.52-1.01],0.0604834989389502
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Viral pneumonia,26347,220,0.88 [0.60-1.30],0.5294431318322574
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27606,174,0.93 [0.61-1.42],0.7313641736716403
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13532,107,1.10 [0.63-1.93],0.7381401622392958
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19989,39,1.25 [0.51-3.10],0.6267735345998389
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,27840,146,1.00 [0.62-1.61],0.9926914866199716
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute gastritis,21030,90,1.33 [0.72-2.43],0.3596311877309017
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,25678,164,0.89 [0.57-1.38],0.5902511075282837
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute peritonitis,27438,89,2.58 [1.44-4.65],0.0015353948877769
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27129,35,0.36 [0.14-0.92],0.0327106831430583
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Barrett oesophagus,21283,343,1.26 [0.93-1.72],0.1392304020135631
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25594,80,1.13 [0.60-2.12],0.7052616872202908
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27585,80,1.13 [0.60-2.13],0.7023218942821005
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,25704,190,0.87 [0.58-1.32],0.519826501299201
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,26720,1206,0.87 [0.74-1.03],0.1071568957845568
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,21288,348,1.11 [0.82-1.51],0.5074806100270581
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25556,42,1.42 [0.59-3.42],0.428645169251985
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27943,75,0.83 [0.43-1.59],0.5756710871402633
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,26436,157,0.94 [0.60-1.49],0.8045951315692519
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Collagenous colitis,26087,116,1.27 [0.75-2.16],0.3809791553762592
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27887,151,0.89 [0.56-1.41],0.6136463611178764
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,27676,1757,0.96 [0.84-1.10],0.5560902553472993
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,26066,95,1.71 [0.95-3.06],0.0734510830104167
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27656,71,1.45 [0.74-2.85],0.2778054413903421
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26070,99,1.83 [1.03-3.24],0.039138410587208
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,27184,234,1.18 [0.82-1.71],0.3786432976658589
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26373,2527,0.94 [0.84-1.05],0.2987449133800852
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,27883,189,0.94 [0.62-1.43],0.7751246697719434
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,27922,828,0.79 [0.65-0.97],0.0219920112953183
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25682,4742,0.93 [0.85-1.01],0.0810957878655681
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27549,599,1.02 [0.81-1.29],0.8478090618623477
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27900,551,0.96 [0.75-1.23],0.7497176975419482
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27071,121,1.32 [0.79-2.21],0.2965647710761019
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26914,64,0.52 [0.26-1.06],0.070495180501687
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27715,1436,1.01 [0.87-1.18],0.8600120747462613
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of tongue,26927,114,1.54 [0.90-2.63],0.1123227161376245
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27135,1621,0.90 [0.78-1.04],0.1415349391257637
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23233,3283,0.83 [0.75-0.91],0.0002075182568251
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,21072,132,0.69 [0.42-1.14],0.1464201987593177
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27975,112,0.69 [0.41-1.18],0.1760936426313603
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27922,65,0.92 [0.45-1.89],0.8240036433557072
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27190,96,0.65 [0.36-1.16],0.1416455434136682
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20064,114,1.06 [0.62-1.82],0.8182053045318058
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,21612,672,0.91 [0.73-1.14],0.4307271322038143
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,21292,352,0.87 [0.64-1.17],0.356127867985658
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23798,2858,0.84 [0.76-0.94],0.0019390011401287
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21416,476,0.81 [0.62-1.05],0.1139043851472527
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21928,8654,0.94 [0.89-1.00],0.0552161548178218
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,27436,1157,0.98 [0.83-1.16],0.794363079465413
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27013,63,0.48 [0.23-0.97],0.0410859171228448
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20944,1289,0.86 [0.73-1.01],0.0577694460542819
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27135,41,1.80 [0.75-4.29],0.1868984363163869
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,26814,2968,0.93 [0.84-1.03],0.1636614816139925
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,27933,60,1.04 [0.49-2.20],0.915914670393562
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impaction of intestines,20016,66,1.54 [0.76-3.10],0.2310873587036927
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,24015,169,0.62 [0.40-0.96],0.0341658367339407
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,20054,104,0.87 [0.49-1.52],0.6196239605858331
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26463,184,1.08 [0.71-1.65],0.718797738025368
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20790,840,0.88 [0.72-1.07],0.1936399804945992
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28011,364,0.72 [0.53-0.96],0.0268168329742999
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26811,840,0.82 [0.68-1.00],0.0515165590409346
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27105,1134,0.93 [0.78-1.10],0.3856400254196738
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21105,165,0.65 [0.41-1.02],0.058718941821511
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,21519,579,0.80 [0.63-1.02],0.0665317546298307
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27981,161,1.00 [0.64-1.57],0.9988592701836818
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23905,59,0.72 [0.34-1.52],0.3951797385475957
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21246,1296,0.82 [0.70-0.97],0.0178879716755584
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25817,303,0.79 [0.57-1.10],0.1604519317046852
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25707,193,0.93 [0.62-1.40],0.7229329311532011
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,21572,1622,0.89 [0.77-1.02],0.1011481665949121
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,25808,5858,0.90 [0.83-0.97],0.004326396469129
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26916,234,0.87 [0.60-1.26],0.4591975506549941
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,27790,696,0.87 [0.70-1.08],0.1967262401434668
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21533,593,0.93 [0.74-1.18],0.554733697507243
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25674,160,1.21 [0.77-1.89],0.407230394876619
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27835,486,0.85 [0.66-1.10],0.2256998989275472
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22052,1112,0.89 [0.75-1.06],0.1899182248087731
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27455,1176,0.98 [0.83-1.16],0.8507749476751628
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27148,198,0.94 [0.63-1.41],0.7613037592644194
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21764,1814,0.91 [0.80-1.04],0.1869582724054065
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23106,2166,0.93 [0.82-1.05],0.2347201516115055
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27196,102,1.31 [0.75-2.30],0.349751718829318
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26968,997,0.88 [0.73-1.05],0.1618836139202182
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20288,338,1.07 [0.79-1.47],0.6548948897088658
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27911,75,0.94 [0.48-1.85],0.8684327795940618
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20454,504,0.96 [0.74-1.24],0.7353315052592156
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26414,135,1.58 [0.97-2.57],0.0665608565375623
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28019,70,1.16 [0.59-2.29],0.6736082874724851
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26951,130,1.07 [0.64-1.76],0.8050812294791655
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Toxic colitis,26038,67,1.58 [0.79-3.17],0.1976065801988801
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21177,237,0.90 [0.62-1.31],0.5869995654473266
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,26145,174,1.36 [0.88-2.10],0.1652083498443087
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26114,143,1.27 [0.79-2.05],0.3254746152143721
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,24021,175,1.24 [0.81-1.90],0.3190728085894398
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,20143,193,0.91 [0.60-1.37],0.6431502898577393
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,24105,259,0.78 [0.55-1.12],0.1777167941347683
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Volvulus,20035,85,0.51 [0.28-0.95],0.0327822986291945
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27939,265,1.07 [0.75-1.52],0.7062363561321597
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27701,77,0.68 [0.36-1.31],0.2484914080626949
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25909,224,0.80 [0.55-1.18],0.2680430170341293
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27487,646,1.10 [0.88-1.37],0.4212036044748177
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26990,149,0.71 [0.44-1.13],0.1485564134216577
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26034,349,0.82 [0.61-1.11],0.2090311128332788
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27707,287,0.87 [0.62-1.22],0.4155192871623195
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27914,494,1.02 [0.79-1.32],0.8765049568046804
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27472,52,0.92 [0.42-2.03],0.840437992052868
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26388,3247,1.01 [0.92-1.12],0.7975018801100598
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27569,493,0.84 [0.65-1.09],0.1973047176029168
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27416,340,0.78 [0.57-1.07],0.1192616821819442
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27704,863,1.00 [0.82-1.21],0.9604133541295884
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28005,80,0.83 [0.44-1.59],0.580634572450522
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25776,91,2.22 [1.24-3.98],0.0074762172745463
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27124,48,1.33 [0.59-3.02],0.4889391633583824
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27691,271,0.93 [0.66-1.32],0.7000973701696132
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26113,428,1.01 [0.76-1.33],0.954172358585784
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25735,50,1.43 [0.64-3.21],0.3844238590477387
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27920,85,1.78 [0.97-3.27],0.0620225168725176
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27001,160,0.72 [0.46-1.13],0.1514992773336805
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27792,168,0.86 [0.56-1.34],0.5125214723114282
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27478,58,1.31 [0.63-2.75],0.4734902189731031
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25752,67,0.60 [0.30-1.21],0.1547022683545709
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27320,1635,1.05 [0.91-1.21],0.5079736725520028
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26149,464,1.16 [0.89-1.51],0.2780755999914273
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25740,55,1.06 [0.49-2.29],0.8835959437345514
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27939,315,0.87 [0.63-1.20],0.4073036892270237
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27505,85,1.22 [0.66-2.25],0.5299790091949659
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27863,239,0.87 [0.60-1.26],0.4706244790463629
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27974,300,1.16 [0.83-1.61],0.392584595893987
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25847,162,0.75 [0.48-1.19],0.221514038872138
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25953,268,1.52 [1.07-2.16],0.0190609246775548
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27961,287,1.14 [0.81-1.60],0.4403158427776326
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25890,205,0.89 [0.60-1.32],0.5751530124255626
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27992,157,1.53 [0.97-2.40],0.0660216691093103
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23913,130,0.85 [0.51-1.42],0.5386341907913323
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25457,6535,0.93 [0.87-1.00],0.0595053005806929
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24030,5108,0.91 [0.84-0.99],0.0215578394956099
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23863,80,1.43 [0.76-2.72],0.2687581809308128
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24041,155,1.38 [0.87-2.18],0.1655862814354682
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24098,212,1.44 [0.98-2.13],0.0649792729458824
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27733,117,1.33 [0.79-2.24],0.2847931257178817
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24007,121,0.61 [0.37-1.03],0.0663236669652587
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20323,1401,0.95 [0.82-1.11],0.5255802048814073
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27873,228,1.03 [0.71-1.50],0.8633704772759164
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24508,622,0.82 [0.65-1.04],0.098548194806739
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23557,8300,0.93 [0.88-1.00],0.0347429124741774
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25111,141,0.82 [0.51-1.33],0.4184628004797486
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23920,137,0.98 [0.60-1.59],0.9287964265346608
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24489,706,1.07 [0.86-1.32],0.5611567774928997
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26986,3100,0.92 [0.83-1.01],0.0895327679303086
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23964,181,0.96 [0.63-1.48],0.8565370161621094
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24169,386,0.85 [0.64-1.14],0.273682460686211
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23959,176,1.04 [0.68-1.61],0.8498319375835535
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27052,111,1.18 [0.68-2.04],0.5528327748571791
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20849,1927,0.87 [0.76-0.99],0.0338842397415866
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19153,231,1.03 [0.71-1.49],0.8721583052157137
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28015,228,1.17 [0.80-1.69],0.4146280789039553
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19025,103,0.95 [0.54-1.68],0.8563971152714425
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19506,584,1.12 [0.88-1.42],0.3514918657238313
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24123,340,0.85 [0.63-1.17],0.320571133806552
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19571,649,0.94 [0.75-1.18],0.6199950098114757
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23955,69,0.76 [0.38-1.51],0.4357163449296669
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24615,729,0.90 [0.73-1.11],0.32047978130012
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24225,339,1.00 [0.73-1.36],0.9872952250827924
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19527,605,0.96 [0.76-1.21],0.7056922483407388
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23879,96,1.84 [1.03-3.29],0.0388709090117576
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23854,71,0.94 [0.47-1.85],0.8551177468343911
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,25021,51,0.72 [0.32-1.60],0.4162501201767471
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27539,2569,0.98 [0.88-1.10],0.743492854030381
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26815,1845,0.98 [0.86-1.12],0.7728922310924075
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27828,618,1.01 [0.80-1.26],0.9522348806778304
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22034,3112,0.88 [0.80-0.98],0.0185215263896551
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18997,75,0.73 [0.37-1.41],0.3445608310745792
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23887,104,1.50 [0.86-2.61],0.1523942288562799
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18965,43,3.08 [1.37-6.89],0.0062671722645429
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19128,206,0.82 [0.55-1.23],0.3316928673441007
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25268,298,1.00 [0.72-1.39],0.987896637573515
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25575,605,1.07 [0.85-1.36],0.5532813839804513
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27997,115,1.15 [0.68-1.96],0.6010024333462818
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25969,2083,0.96 [0.84-1.08],0.4944515485797728
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23918,135,0.88 [0.54-1.45],0.6189529287469568
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19162,240,1.20 [0.83-1.75],0.3243382520780178
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24723,837,0.99 [0.81-1.21],0.931400086138884
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21529,2607,0.99 [0.89-1.11],0.9253929804899432
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27077,136,1.26 [0.77-2.06],0.3600184820770132
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28007,77,0.74 [0.39-1.41],0.3579663222596669
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23866,83,0.87 [0.46-1.62],0.6509255965848675
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25305,1522,1.04 [0.90-1.20],0.6100436811470428
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23867,84,0.92 [0.49-1.71],0.7846462286473731
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20959,2037,0.85 [0.75-0.97],0.0143480951712475
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25109,139,0.75 [0.46-1.22],0.2428301796651174
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23847,64,0.99 [0.48-2.04],0.9758419464426412
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24094,208,0.97 [0.65-1.44],0.8838789749526492
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24389,606,1.21 [0.96-1.52],0.1078482584727049
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27461,520,1.09 [0.85-1.41],0.4867647174556968
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24546,660,1.22 [0.98-1.53],0.0707838160978134
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27843,598,1.01 [0.80-1.27],0.9323506761030246
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27999,69,0.91 [0.46-1.81],0.7873045242743835
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24013,230,0.94 [0.65-1.38],0.7677469542543771
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21509,939,1.10 [0.91-1.33],0.3147650664272411
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24472,689,1.02 [0.82-1.26],0.8763801264898488
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23910,127,0.90 [0.54-1.50],0.6822778703480437
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",19000,78,1.08 [0.57-2.06],0.8126423053831477
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21630,2708,0.86 [0.77-0.96],0.0079131209272444
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19783,861,0.80 [0.66-0.98],0.0269828676068777
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27244,303,1.14 [0.82-1.58],0.4411200623806663
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27967,85,1.20 [0.65-2.23],0.5551440175840289
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25668,57,0.80 [0.38-1.68],0.557336552861798
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,19000,78,0.65 [0.34-1.25],0.2001842776038732
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24000,114,1.03 [0.60-1.76],0.9073646972631076
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19544,622,0.94 [0.75-1.19],0.6241262134532317
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24124,341,0.89 [0.65-1.21],0.4419712981688997
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24178,292,0.98 [0.70-1.37],0.9082967324821558
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24170,284,0.65 [0.46-0.91],0.0130111705060357
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21634,84,0.82 [0.44-1.54],0.5408636230146051
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28006,76,1.06 [0.55-2.04],0.8537183753971966
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24441,658,0.89 [0.71-1.11],0.2840278877851231
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],27108,167,1.07 [0.69-1.67],0.7647889577248116
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26679,2896,1.03 [0.93-1.15],0.5725594517343671
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23941,158,1.04 [0.66-1.64],0.8574061115925392
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24466,580,1.26 [0.99-1.59],0.0574864545096731
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26262,273,0.87 [0.62-1.23],0.4329653559515939
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24171,285,1.12 [0.80-1.57],0.502013064434029
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25695,1809,0.96 [0.84-1.10],0.5343463750735599
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25114,1228,1.01 [0.86-1.19],0.9286203294154096
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23849,66,1.43 [0.72-2.86],0.3105409456415565
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27172,231,0.94 [0.65-1.37],0.744127920630581
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23990,207,1.59 [1.07-2.37],0.0220794265107822
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23913,130,1.15 [0.70-1.90],0.5802009388040601
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18979,57,1.09 [0.51-2.31],0.8278281186735734
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26920,1283,1.72 [1.47-2.02],1.7184281184506757e-11
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20977,102,1.02 [0.58-1.79],0.9506890219784412
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27314,111,0.82 [0.48-1.42],0.4829090464825655
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27859,239,1.27 [0.88-1.83],0.2074877594385374
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27648,28,0.57 [0.19-1.68],0.3088358306698132
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27168,1531,3.52 [3.06-4.05],2.4389804434759558e-70
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27850,80,6.87 [4.01-11.78],2.410390804051818e-12
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27811,245,1.27 [0.88-1.82],0.1975629317714232
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,24719,257,0.75 [0.52-1.07],0.11432080774218
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dialysis,25690,53,14.74 [8.35-26.04],1.8338180213262875e-20
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27547,344,0.96 [0.71-1.31],0.80361201400616
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,21058,183,1.25 [0.82-1.91],0.2935441886114849
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21276,401,0.76 [0.57-1.01],0.0618539351592974
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21900,1025,0.67 [0.56-0.80],1.4160892431010106e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21815,5177,1.07 [0.99-1.16],0.1033311783785856
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27834,64,4.07 [2.07-8.01],4.852856580343745e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25513,216,1.03 [0.69-1.52],0.8929630283517836
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27463,408,0.89 [0.67-1.18],0.4171446834543157
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,27554,131,0.74 [0.44-1.22],0.2313739384601584
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21183,308,0.79 [0.57-1.10],0.1634843803641995
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24543,81,0.46 [0.25-0.87],0.0170321061058403
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23380,2505,0.83 [0.74-0.93],0.0011110300874596
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21020,145,0.88 [0.55-1.42],0.6109895227576312
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28013,68,0.80 [0.40-1.59],0.5185333253195077
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28017,76,0.55 [0.29-1.06],0.0723997820275088
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26753,2291,0.94 [0.83-1.05],0.2769351393591508
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24948,486,0.71 [0.55-0.93],0.0112207647505068
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27323,120,1.01 [0.60-1.71],0.961202412834574
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27962,396,1.53 [1.15-2.03],0.0034610858783961
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27966,91,0.51 [0.28-0.93],0.0267688851788907
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26427,1965,1.01 [0.88-1.14],0.9357374710752184
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27267,212,0.90 [0.61-1.33],0.5989124626691831
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21033,158,0.70 [0.44-1.10],0.1236426813536785
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21254,379,0.94 [0.70-1.26],0.6749931153504689
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20991,116,0.56 [0.33-0.96],0.0341488189224089
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21083,208,0.61 [0.41-0.91],0.0162324812465652
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25564,267,1.22 [0.86-1.74],0.2697857110676333
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27695,129,1.27 [0.77-2.09],0.353997695899702
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21192,317,1.08 [0.79-1.50],0.6240187028488473
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20984,109,0.67 [0.39-1.15],0.1482105029858049
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21534,659,0.84 [0.67-1.05],0.1182059857400628
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21037,162,0.92 [0.59-1.45],0.7242839561982559
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21476,601,0.75 [0.60-0.95],0.0161139437446304
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27808,38,2.14 [0.86-5.33],0.1028842046079191
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27828,2531,1.96 [1.75-2.19],1.8424754122168768e-31
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25463,166,1.18 [0.75-1.84],0.4810147673464788
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25740,103,5.80 [3.48-9.66],1.4344244401890274e-11
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27656,36,0.89 [0.34-2.28],0.8011278127935393
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24610,148,0.87 [0.55-1.40],0.5760416136518538
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27894,274,1.20 [0.85-1.69],0.2988630293156888
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21019,144,0.74 [0.46-1.19],0.2142578557999254
